Home Cart Sign in  
Chemical Structure| 1438391-30-0 Chemical Structure| 1438391-30-0

Structure of CC-401 HCl
CAS No.: 1438391-30-0

Chemical Structure| 1438391-30-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CC-401 HCl is a selective and ATP-competitive JNK inhibitor with Ki values ranging in 25-50 nM.

Synonyms: CC-401 Hydrochloride

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CC-401 HCl

CAS No. :1438391-30-0
Formula : C22H25ClN6O
M.W : 424.93
SMILES Code : [H]Cl.C1(C2=CC=CC(OCCN3CCCCC3)=C2)=NNC4=C1C=C(C5=NC=NN5)C=C4
Synonyms :
CC-401 Hydrochloride
MDL No. :MFCD21364765
InChI Key :OIBVXKYKWOUGAO-UHFFFAOYSA-N
Pubchem ID :66576998

Safety of CC-401 HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of CC-401 HCl

MAPK
TLR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HCT116 colon cancer cells 3.5 μM 24 h To evaluate the inhibitory effect of CC-401 on JNK signaling and its enhancement of oxaliplatin cytotoxicity under hypoxia in HCT116 cells. Results showed that CC-401 significantly inhibited JNK signaling, but the enhancement of cytotoxicity was less pronounced compared to HT29 and SW620 cells. Clin Cancer Res. 2015 Sep 15;21(18):4143-52
SW620 colon cancer cells 6.5 μM 24 h To evaluate the inhibitory effect of CC-401 on JNK signaling and its enhancement of oxaliplatin cytotoxicity under hypoxia in SW620 cells. Results showed that CC-401 significantly inhibited JNK signaling and enhanced oxaliplatin cytotoxicity. Clin Cancer Res. 2015 Sep 15;21(18):4143-52
HT29 colon cancer cells 3 μM 24 h To evaluate the inhibitory effect of CC-401 on JNK signaling and its enhancement of oxaliplatin cytotoxicity under hypoxia in HT29 cells. Results showed that CC-401 significantly inhibited JNK signaling and enhanced oxaliplatin cytotoxicity. Clin Cancer Res. 2015 Sep 15;21(18):4143-52

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C.B.17 SCID mice HT29-derived mouse xenografts Intraperitoneal injection 25 mg/kg Every 3 days for 21 days To evaluate the enhancing effect of CC-401 on the combination therapy of oxaliplatin and bevacizumab. Results showed that CC-401 significantly prolonged tumor growth delay and enhanced the efficacy of oxaliplatin and bevacizumab. Clin Cancer Res. 2015 Sep 15;21(18):4143-52

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.35mL

0.47mL

0.24mL

11.77mL

2.35mL

1.18mL

23.53mL

4.71mL

2.35mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories